Oncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3

International Journal of Molecular Medicine

Volumn 28, Issue 1, 2011, Pages 101-108

  Li, Qinhua ^a   Zhu, Jihong ^a   Sun, Fei ^a   Liu, Lei ^a   Liu, Xiaoxia ^a   Yue, Ying ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Epithelial ovarian cancer; ERK1 2; Oncostatin M; p38; STAT3

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOSTATIN M; PHOSPHOPROTEIN; STAT3 PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; ONCOSTATIN M; OVARIAN NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RECOMBINANT PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

EID: 79955818331     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.647     Document Type: Article

References (34)

1. Lahiri T, Laporte JD, Moore PE, Panettieri RA and Shore SA: Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 280: 1225-1232, 2001.
2. Grenier A, Dehoux M, Boutten A, Arce-Vicioso M, Durand G, Gougerot-Pocidalo MA and Chollet-Martin S: Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 93: 1413-1421, 1999. (Pubitemid 29076158)
3. Horn D, Fitzpatrick WC, Gompper PT, Ochs V, Bolton-Hansen M, Zarling J, Malik N, Todaro GJ and Linsley PS: Regulation of cell growth by recombinant oncostatin M. Growth Factors 2: 157-165, 1990. (Pubitemid 20057753)
4. Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA and Begley CG: Expression and function of members of the cytokine receptor superfamily on breast cancer cells. Oncogene 14: 661-669, 1997. (Pubitemid 27095857)
5. Grove R I, Eberhardt C, Abid S, Mazzucco C, Liu J, Kiener P, Todaro G and Shoyab M: Oncostatin M is a mitogen for rabbit vascular smooth muscle cells. Proc Natl Acad Sci USA 90: 823-827, 1993. (Pubitemid 23053902)
6. Zhang XG, Gu JJ, Lu ZY, Yasukawa K, Yancopoulos GD, Turner K, Shoyab M, Taga T, Kishimoto T and Bataille R: Ciliary neurotrophic factor, interleukin 11, leukemia inhibitory factor and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. J Exp Med 179: 1343-1347, 1994.
7. Nair BC, DeVico AL, Nakamura S, Copeland TD, Chen Y, Patel A, O'Neil T, Oroszlan S, Gallo RC and Sarngadharan MG: Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science 255: 1430-1432, 1992.
8. Holzer RG, Ryan RE, Tommack M, Schlekeway E and Jorcyk CL: Oncostatin M stimulates the detachment of a reservoir of invasive mammary carcinoma cells: role of cyclo-oxygenase-2. Clin Exp Metastasis 21: 167-176, 2004. (Pubitemid 38988090)
9. Queen MM, Ryan RE, Holzer RG, Keller-Peck CR and Jorcyk CL: Breast cancer cells stimulate neutrophils to produce oncostatin M: potential implications for tumor progression. Cancer Res 65: 8896-8904, 2005. (Pubitemid 41377379)
10. Durda PJ, Dunn IS, Rose LB, Butera D, Benson EM, Pandolfi F and Kurnick JT: Induction of 'antigen silencing' in melanomas by oncostatin M: down-modulation of melanocyte antigen expression. Mol Cancer Res 1: 411-419, 2003.
11. Hurst SM, McLoughlin RM, Monslow J, Owens S, Morgan L, Fuller GM, Topley N and Jones SA: Secretion of oncostatin M by infiltrating neutrophils: regulation of IL-6 and chemokine expression in human mesothelial cells. J Immunol 169: 5244-5251, 2002. (Pubitemid 35217196)
12. Korzus E, Nagase H, Rydell R and Travis J: The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem 272: 1188-1196, 1997. (Pubitemid 27034616)
13. Porter AC and Vaillancourt RR: Tyrosine kinase receptor-activated signal transduction pathways which lead to oncogenesis. Oncogene 17: 1343-1352, 1998. (Pubitemid 28458404)
14. Fukada T, Hibi M, Yamanaka Y, Takahashi-Tezuka M, Fujitani Y, Yamaguchi T, Nakajima K and Hirano T: Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity 5: 449-460, 1996. (Pubitemid 26423473)
15. Minami M, Inoue M, Wei S, Takeda K, Matsumoto M, Kishimoto T and Akira S: STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci USA 93: 3963-3966, 1996. (Pubitemid 26144231)
16. Bellido T, Borba VZ, Roberson P and Manolagas SC: Activation of the Janus Kinase/STAT (signal transduction and activatorof transcription) signal transduction pathway by interleukin-6 type cytokines promotes osteoblast differentiation. Endocrinology 138: 3666-3676, 1997. (Pubitemid 27351915)
17. Li C, Ahlborn TE, Kraemer FB and Liu J: Oncostatin M-induced growth inhibition and morphological changes of MDA-MB231 breast cancer cells are abolished by blocking the MEK/ERK signaling pathway. Breast Cancer Res Treat 66: 111-121, 2001. (Pubitemid 32521417)
18. Hohensinner PJ, Kaun C, Rychli K, Niessner A, Pfaffenberger S, Rega G, Furnkranz A, Uhrin P, Zaujec J, Afonyushkin T, Bochkov VN, Maurer G, Huber K and Wojta J: The inflammatory mediator oncostatin M induces stromal derived factor-1 in human adult cardiac cell. FASEB J 23: 774-782, 2009.
19. Vollmer S, Kappler V, Kaczor J, Flügel D, Rolvering C, Kato N, Kietzmann T, Behrmann I and Haan C: Hypoxia-Inducible factor 1 is up-regulated by oncostatin M and participates in oncostatin M signaling. Hepatology 50: 253-260, 2009.
20. Repovic P, Mi K and Benveniste EN: Oncostatin M enhances the expression of prostaglandin E2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1, tumor necrosis factor-alpha and bacterial lipopolysaccharide. Glia 42: 433-446, 2003. (Pubitemid 36702284)
21. Thoma B, Bird TA, Friend DJ, Gearing DP and Dower SK: Oncostatin M and leukemia inhibitory factor trigger overlapping and different signals through partially shared receptor complexes. J Biol Chem 269: 6215-6222, 1994. (Pubitemid 24243012)
22. Mosley B, De Imus C, Friend D, Boiani N, Thoma B, Park LS and Cosman D: Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635-32643, 1996. (Pubitemid 27008685)
23. Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A and Gascan H: Signaling of type II oncostatin M receptor. J Biol Chem 272: 15760-15764, 1997. (Pubitemid 27265551)
24. Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ and Nelson BE: Co-expression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas. Cytokine 17: 324-334, 2002.
25. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR and Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
26. Jiang Y, Chen C, Li Z, Guo W, Gegner JA, Lin S and Han J: Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 271: 17920-17926, 1996. (Pubitemid 26250772)
27. Miles SA, Martínez-Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF and Linsley PS: Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255: 1432-1434, 1992.
28. Nishimoto N, Ogata A, Shima Y, Tani Y, Ogawa H, Nakagawa M, Sugiyama H, Yoshizaki K and Kishimoto T: Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med 179: 1343-1347, 1994. (Pubitemid 24091793)
29. Westendorf JJ and Jelinek DF: Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. J Immunol 157: 3081-3088, 1996. (Pubitemid 126450068)
30. Mori S, Murakami-Mori K and Bonavida B: Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells but not PC-3 or LNCaP, through signaling of the OM specific receptor. Anticancer Res 19: 1011-1015, 1999. (Pubitemid 29257530)
31. Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE and McCubrey JA: JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18: 189-218, 2004. (Pubitemid 38240034)
32. Krasilnikov M, Ivanov VN, Dong J and Ronai Z: ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. Oncogene 22: 4092-4101, 2003. (Pubitemid 36819649)
33. Xu B, Bhattacharjee A, Roy B, Xu HM, Anthony D, Frank DA, Feldman GM and Cathcart MK: Interleukin-13 induction of 15-lipoxygenase gene expression requires p38 mitogen-activated protein kinase-mediated serine 727 phosphorylation of Stat1 and Stat3. Mol Cell Biol 23: 3918-3928, 2003. (Pubitemid 36597470)
34. Ng DC, Long CS and Bogoyevitch MA: A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte morphology. J Biol Chem 276: 29490-29498, 2001.